IMMUTEP LIMITED - AMER
2.0500
07-十月-24 15:59:57
15 分钟延时
股票
0.0000
0.00%
今日范围
2.0200 - 2.0900
ISIN
N/A
来源
NASDAQ
-
Immutep Appoints Dr. Florian Vogl as Chief Medical Officer
26 4月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
17 4月 2023 09:00:00 条件 Nasdaq GlobeNewswire
-
31 3月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer
30 3月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
23 3月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
14 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Immutep Reaches Enrolment Target for INSIGHT-003 Trial in 1st Line NSCLC
06 2月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
30 1月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
04 1月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
23 12月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Successfully Achieves Commercial Scale in Manufacturing of Eftilagimod Alpha
08 12月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
06 12月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Immutep to Participate in The JMP Securities Hematology and Oncology Summit
02 12月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Receives Australian R&D Tax Incentive
14 11月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Immutep Announces Promising Initial Clinical Data from INSIGHT-003 at SITC 2022
10 11月 2022 09:00:02 条件 Nasdaq GlobeNewswire
-
09 11月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
04 11月 2022 08:00:00 条件 Nasdaq GlobeNewswire